205 related articles for article (PubMed ID: 22362562)
41. Working your SOCS off: The role of ASB10 and protein degradation pathways in glaucoma.
Keller KE; Wirtz MK
Exp Eye Res; 2017 May; 158():154-160. PubMed ID: 27296073
[TBL] [Abstract][Full Text] [Related]
42. In vitro ubiquitination of cytokine signaling components.
Babon JJ; Laktyushin A; Kershaw NJ
Methods Mol Biol; 2013; 967():261-71. PubMed ID: 23296736
[TBL] [Abstract][Full Text] [Related]
43. Suppressor of cytokine signaling 3 inhibits head kidney macrophage activation and cytokine expression in Scophthalmus maximus.
Zhang M; Xiao ZZ; Sun L
Dev Comp Immunol; 2011 Feb; 35(2):174-81. PubMed ID: 20869394
[TBL] [Abstract][Full Text] [Related]
44. Unbiased identification of substrates for the Epac1-inducible E3 ubiquitin ligase component SOCS-3.
Williams JJ; Palmer TM
Biochem Soc Trans; 2012 Feb; 40(1):215-8. PubMed ID: 22260693
[TBL] [Abstract][Full Text] [Related]
45. Understanding SOCS protein specificity.
Linossi EM; Calleja DJ; Nicholson SE
Growth Factors; 2018 Aug; 36(3-4):104-117. PubMed ID: 30318950
[TBL] [Abstract][Full Text] [Related]
46. The SPRY domain-containing SOCS box protein SPSB2 targets iNOS for proteasomal degradation.
Kuang Z; Lewis RS; Curtis JM; Zhan Y; Saunders BM; Babon JJ; Kolesnik TB; Low A; Masters SL; Willson TA; Kedzierski L; Yao S; Handman E; Norton RS; Nicholson SE
J Cell Biol; 2010 Jul; 190(1):129-41. PubMed ID: 20603330
[TBL] [Abstract][Full Text] [Related]
47. SOCS-6 binds to insulin receptor substrate 4, and mice lacking the SOCS-6 gene exhibit mild growth retardation.
Krebs DL; Uren RT; Metcalf D; Rakar S; Zhang JG; Starr R; De Souza DP; Hanzinikolas K; Eyles J; Connolly LM; Simpson RJ; Nicola NA; Nicholson SE; Baca M; Hilton DJ; Alexander WS
Mol Cell Biol; 2002 Jul; 22(13):4567-78. PubMed ID: 12052866
[TBL] [Abstract][Full Text] [Related]
48. A label-free quantitative proteomics strategy to identify E3 ubiquitin ligase substrates targeted to proteasome degradation.
Burande CF; Heuzé ML; Lamsoul I; Monsarrat B; Uttenweiler-Joseph S; Lutz PG
Mol Cell Proteomics; 2009 Jul; 8(7):1719-27. PubMed ID: 19376791
[TBL] [Abstract][Full Text] [Related]
49. Crystallization and preliminary X-ray analysis of the splice variant of human ankyrin repeat and suppressor of cytokine signaling box protein 9 (hASB9-2).
Fei X; Zhang Y; Gu X; Qiu R; Mao Y; Ji C
Protein Pept Lett; 2008; 15(6):647-9. PubMed ID: 18680464
[TBL] [Abstract][Full Text] [Related]
50. Optimization of Phosphotyrosine Peptides that Target the SH2 Domain of SOCS1 and Block Substrate Ubiquitination.
Chen H; Wu Y; Li K; Currie I; Keating N; Dehkhoda F; Grohmann C; Babon JJ; Nicholson SE; Sleebs BE
ACS Chem Biol; 2022 Feb; 17(2):449-462. PubMed ID: 34989544
[TBL] [Abstract][Full Text] [Related]
51. The structure of SOCS3 reveals the basis of the extended SH2 domain function and identifies an unstructured insertion that regulates stability.
Babon JJ; McManus EJ; Yao S; DeSouza DP; Mielke LA; Sprigg NS; Willson TA; Hilton DJ; Nicola NA; Baca M; Nicholson SE; Norton RS
Mol Cell; 2006 Apr; 22(2):205-16. PubMed ID: 16630890
[TBL] [Abstract][Full Text] [Related]
52. The SOCS box: a tale of destruction and degradation.
Kile BT; Schulman BA; Alexander WS; Nicola NA; Martin HM; Hilton DJ
Trends Biochem Sci; 2002 May; 27(5):235-41. PubMed ID: 12076535
[TBL] [Abstract][Full Text] [Related]
53. Regulation of cytokine-inducible SH2-containing protein (CIS) by ubiquitination and Elongin B/C interaction.
Jensik PJ; Arbogast LA
Mol Cell Endocrinol; 2015 Feb; 401():130-41. PubMed ID: 25448846
[TBL] [Abstract][Full Text] [Related]
54. Structure of the SOCS4-ElonginB/C complex reveals a distinct SOCS box interface and the molecular basis for SOCS-dependent EGFR degradation.
Bullock AN; Rodriguez MC; Debreczeni JE; Songyang Z; Knapp S
Structure; 2007 Nov; 15(11):1493-504. PubMed ID: 17997974
[TBL] [Abstract][Full Text] [Related]
55. Gonadotropin regulation of ankyrin-repeat and SOCS-box protein 9 (ASB9) in ovarian follicles and identification of binding partners.
Benoit G; Warma A; Lussier JG; Ndiaye K
PLoS One; 2019; 14(2):e0212571. PubMed ID: 30811458
[TBL] [Abstract][Full Text] [Related]
56. Ankyrin repeat and SOCS box containing protein 4 (Asb-4) interacts with GPS1 (CSN1) and inhibits c-Jun NH2-terminal kinase activity.
Li JY; Chai BX; Zhang W; Liu YQ; Ammori JB; Mulholland MW
Cell Signal; 2007 Jun; 19(6):1185-92. PubMed ID: 17276034
[TBL] [Abstract][Full Text] [Related]
57. Ankyrin-repeat and SOCS box-containing protein 9 (ASB9) regulates ovarian granulosa cells function and MAPK signaling.
Nosratpour S; Ndiaye K
Mol Reprod Dev; 2021 Dec; 88(12):830-843. PubMed ID: 34476862
[TBL] [Abstract][Full Text] [Related]
58. Hsp90 inhibition renders iNOS aggregation and the clearance of iNOS aggregates by proteasomes requires SPSB2.
Wang T; Luo S; Qin H; Xia Y
Free Radic Biol Med; 2018 Mar; 117():90-98. PubMed ID: 29367003
[TBL] [Abstract][Full Text] [Related]
59. Signaling Size: Ankyrin and SOCS Box-Containing ASB E3 Ligases in Action.
Liu P; Verhaar AP; Peppelenbosch MP
Trends Biochem Sci; 2019 Jan; 44(1):64-74. PubMed ID: 30446376
[TBL] [Abstract][Full Text] [Related]
60. A mechanism underlying NOTCH-induced and ubiquitin-mediated JAK3 degradation.
Wu W; Sun XH
J Biol Chem; 2011 Dec; 286(48):41153-41162. PubMed ID: 21969365
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
